Social
Amgen is one of the world's largest biotechnology companies and was among the first, founded in 1980. It develops medicines for conditions such as heart disease, bone loss and cancer. This contract tracks the price of Amgen stock (AMGN). Its business depends on sales of its current medicines and the success of new ones in testing and approval. Older drugs eventually face cheaper copies from competitors, which makes new medicines important to long-term sales.
What to watch: Quarterly earnings, results from new drug studies, government approval decisions, and drug pricing policy.